Krka, d. d., Novo mesto:企業の戦略・SWOT・財務情報

◆英語タイトル:Krka, d. d., Novo mesto - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C1943
◆発行会社(調査会社):MarketLine
◆発行日:2018年7月
◆ページ数:44
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スロベニア
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Krka, d. d., Novo mesto – Strategy, SWOT and Corporate Finance Report
Summary

Krka, d. d., Novo mesto – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Krka, d. d., Novo mesto (Krka or ‘the group’), is a Slovenia-based generic pharmaceutical company. The group provides prescription pharmaceuticals, non-prescription products and animal health products. The group is also involved in the health resort business and provides tourist services. The group markets products under Atoris, Roswera, Ampril, Lorista, Septolete, Pikovit, Bilobil, Flebaven, Fypryst, Enroxil Amatib, Otoxolan and Flimabend brands, among otehrs. The group primarily operates in Europe, Middle East and Africa and the Americas. Krka is headquartered in Novo Mesto, Slovenia.

Scope

- Detailed information on Krka, d. d., Novo mesto required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Krka, d. d., Novo mesto in the form of a SWOT analysis
- An in-depth view of the business model of Krka, d. d., Novo mesto including a breakdown and examination of key business segments
- Intelligence on Krka, d. d., Novo mesto’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Krka, d. d., Novo mesto, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Krka, d. d., Novo mesto and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Krka, d. d., Novo mesto as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Krka, d. d., Novo mesto’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
Krka, d. d., Novo mesto: Company Overview 9
Krka, d. d., Novo mesto: Overview and Key Facts 9
Krka, d. d., Novo mesto: Overview 9
Krka, d. d., Novo mesto: Key Facts 9
Krka, d. d., Novo mesto: Key Employees 11
Krka, d. d., Novo mesto: Key Employee Biographies 14
Krka, d. d., Novo mesto: Major Products and Services 15
Krka, d. d., Novo mesto: Company History 18
Krka, d. d., Novo mesto: Management Statement 20
Krka, d. d., Novo mesto: Locations and Subsidiaries 24
Krka, d. d., Novo mesto: Key Competitors 25
Krka, d. d., Novo mesto: Company Analysis 26
Krka, d. d., Novo mesto: Business Description 26
Krka, d. d., Novo mesto: SWOT Analysis 28
Krka, d. d., Novo mesto: SWOT Overview 28
Krka, d. d., Novo mesto: Strengths 28
Krka, d. d., Novo mesto: Weaknesses 29
Krka, d. d., Novo mesto: Opportunities 29
Krka, d. d., Novo mesto: Threats 30
Krka, d. d., Novo mesto: Corporate Financial Deals Activity 32
Krka, d. d., Novo mesto: Financial Deals Overview 32
Krka, d. d., Novo mesto: Targets and Partners 34
Krka, d. d., Novo mesto: Top Deals 2014 – 2018YTD* 35
Krka, d. d., Novo mesto: Mergers and Acquisitions 36
Krka, d. d., Novo mesto: Partnership 37
Krka, d. d., Novo mesto: Recent Developments 38
Krka, d. d., Novo mesto: News and Events Summary 38
Krka, d. d., Novo mesto: Financial Performance 39
Krka, d. d., Novo mesto: Market Developments 40
Appendix 42
Contact Us 42
Methodology 42
About MarketLine 43

List of Tables
Table 1: Krka, d. d., Novo mesto: Key Facts
Table 2: Krka, d. d., Novo mesto: Key Employees
Table 3: Krka, d. d., Novo mesto: Locations and Subsidiaries
Table 4: Krka, d. d., Novo mesto: Key Competitors
Table 5: Krka, d. d., Novo mesto: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Krka, d. d., Novo mesto: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 7: Krka, d. d., Novo mesto: Targets and Partners
Table 8: Krka, d. d., Novo mesto: Top Deals 2014 - 2018YTD*
Table 9: Krka, d. d., Novo mesto: M&A Volume and Value Trend (2014 - YTD*2018)
Table 10: Krka, d. d., Novo mesto: Partnership Volume and Value Trend (2014 - YTD*2018)
Table 11: Krka, d. d., Novo mesto: Partnership Trend by Deal Type (2014 - YTD*2018)
Table 12: Krka, d. d., Novo mesto: News and Events Summary
Table 13: Krka, d. d., Novo mesto: Financial Performance
Table 14: Krka, d. d., Novo mesto: Market Developments

List of Figures
Figure 1: Krka, d. d., Novo mesto: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Krka, d. d., Novo mesto: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 3: Krka, d. d., Novo mesto: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 4: Krka, d. d., Novo mesto: Partnership Volume and Value Trend (2014 - YTD*2018)
Figure 5: Krka, d. d., Novo mesto: Partnership Trend by Deal Type (2014 - YTD*2018)

★海外企業調査レポート[Krka, d. d., Novo mesto:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • PT Kimia Farma (KAEF):企業の財務・戦略的SWOT分析
    PT Kimia Farma (KAEF) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Xtant Medical Holdings Inc (XTNT):製薬・医療:M&Aディール及び事業提携情報
    Summary Xtant Medical Holdings Inc (Xtant Medical), formerly Bacterin International Holdings Inc, is a medical device company that develops regenerative medicine products and medical devices. The company’s products include 3Demin, osteosponge, osteosponge SC, osteoselect DBM Putty, OsteoSTX, osteowr …
  • Kohler Co.:企業の戦略・SWOT・財務分析
    Kohler Co. - Strategy, SWOT and Corporate Finance Report Summary Kohler Co. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Aaron’s Inc:企業の戦略・SWOT・財務分析
    Aaron's Inc - Strategy, SWOT and Corporate Finance Report Summary Aaron's Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • PT Adaro Energy Tbk:企業の戦略・SWOT・財務情報
    PT Adaro Energy Tbk - Strategy, SWOT and Corporate Finance Report Summary PT Adaro Energy Tbk - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Serco Group plc:企業の戦略・SWOT・財務情報
    Serco Group plc - Strategy, SWOT and Corporate Finance Report Summary Serco Group plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Zocere Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Zocere Inc (Zocere), formerly Tyrosine Pharmaceuticals Inc is a biotechnology company that develops novel therapeutics for neurological diseases. The company offers services to support the pharmaceutical and biotechnology fields developing stroke-related diagnostics and treatments. Its drugs …
  • Bob Evans Farms, Inc.:企業の戦略・SWOT・財務分析
    Bob Evans Farms, Inc. - Strategy, SWOT and Corporate Finance Report Summary Bob Evans Farms, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Harvey Norman Holdings Ltd (HVN):企業の財務・戦略的SWOT分析
    Harvey Norman Holdings Ltd (HVN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Biotest AG (BIO):製薬・医療:M&Aディール及び事業提携情報
    Summary Biotest AG (Biotest) provides pharmaceutical and biotherapeutic drugs. It develops, manufactures and distributes biological medicines through its value chain from preclinical and clinical development to sales. Its main products comprise clotting factors, immunoglobulins, albumin and monoclon …
  • EDF Luminus SA:企業の戦略的SWOT分析
    EDF Luminus SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Consumers Energy Co (CMS PR B):企業の財務・戦略的SWOT分析
    Consumers Energy Co (CMS PR B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Dauntless Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary Dauntless Pharmaceuticals Inc (Dauntless) is a biotech company that develops therapeutic agents. The company’s pipeline product include DP1038, a therapeutic agent used for the treatment of endocrine cancers. It operates through various stages of development. Dauntless manages the developmen …
  • Nutricia GmbH:企業の戦略的SWOT分析
    Nutricia GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Midsona AB (MSON B):企業の財務・戦略的SWOT分析
    Summary Midsona AB (Midsona), is a healthcare products manufacturing company that provides personal care products, health foods, and hygiene products. The company’s products include superfood, sports nutrition, dietary supplements, nutritional supplements, organic food, herbal teas, skin-care and be …
  • Weatherford International Ltd.:企業のM&A・事業提携・投資動向
    Weatherford International Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Weatherford International Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers a …
  • CEL-SCI Corp (CVM):企業の財務・戦略的SWOT分析
    CEL-SCI Corp (CVM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Applebee’s Restaurants LLC:企業の戦略・SWOT・財務情報
    Applebee's Restaurants LLC - Strategy, SWOT and Corporate Finance Report Summary Applebee's Restaurants LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • East-Central Iowa Rural Electric Cooperative:発電所・企業SWOT分析
    East-Central Iowa Rural Electric Cooperative - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, inf …
  • ProteinSimple-医療機器分野:企業M&A・提携分析
    Summary ProteinSimple, formerly Cell Biosciences Inc, a subsidiary of Bio Techne Corp, is a medical device company that offers protein analysis solutions. The company offers products such as simple plex systems, simple western systems, micro-flow imaging systems, cIEF and CE-SDS; gel documentation s …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆